A new disability support system, including a new funding model, will be trialled from 1 October in the MidCentral District Health Board (DHB).The new Enabling Good Lives (EGL) initiative shifts the
Since the recent launch of Alcon’s world-first AutonoMe preloaded IOL delivery system with the Clareon intraocular lens (IOL) in Sydney, several ophthalmologists at Tauranga Eye Specialists have been accredited to use the device.
Today’s practice owner has access to more information and insights into how the practice is performing than ever before. With a focused approach, you will be able to monitor key metrics delivering improved results.
Ocular surface infestation with Demodex mites is recognised as a significant risk factor for the development of chronic blepharitis. Although 50% tea tree oil (Melaleuca alternifolia) is currently the
A study published in Clinical Ophthalmology suggests a single application of self-retained cryopreserved amniotic membrane (CAM) can speed corneal surface recovery and help reduce symptoms of dry eye
Like most folk I always regarded walking from A to B as a fairly mundane but pleasant way of getting around, until recently. Now, sadly it’s a combination of challenge, risk and bloody nuisance, brought about by sight loss and relocating to Auckland.
The Age-Related Eye Disease Study (AREDS) study in 2001 and the AREDS2 study (2013), recommend that patients with intermediate stage age-related macular degeneration (AMD) supplement with a vitamin and antioxidant combination known as the AREDS formula. This can slow down progression to late disease
Phase I clinical study of an embryonic stem cell–derived retinal pigment epithelium patch; Transplantation of human embryonic stem cell-derived retinal pigment epithelial cells in macular degeneration; The 2016 American Academy of Ophthalmology IRIS registry database
Down Syndrome (DS), trisomy of chromosome 21, is one of the most common genetic causes of intellectual disability. It affects 50-80 newborns annually in New Zealand, with advanced maternal age being the primary risk factor. This article encompasses the ophthalmic impairment and clinical consideratio
In NZ Optics April 2018 issue, a frustrated Chalkeyes pondered: “Imagine if our clinical data could be anonymous and pooled. What learning is hidden in those little boxes on our screens from all our patients across the country or even the world¹?” I couldn’t agree more. Why are we wasting all this
By Darin Goldman, Nadia Waheed and Jay Duker , Reviewed by Dr Narme Deva The Atlas of Retinal OCT: Optical Coherence Tomography by Darin Goldman et al is rather a nice little book. On first impressions, it is a little on the skinny side for an ophthalmology atlas, but it is jam-packed with lovely p
This year’s Ophthalmic Nurses Group meeting was held at the Hilton Auckland alongside The New Zealand branch of RANZCO and the orthoptist’s meeting. There was no conference theme as such, but the conference organisers did themselves proud as speakers covered a diverse range of topics, reflecting the
